Catégorie
Fluvoxamine
Numéro CAS
61718-80-7
Formule moléculaire
C₁₃H₁₅F₃O₂
Masse moléculaire
260.25 g/mol
Synonyme

5-Methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one; (4-Methoxybutyl)(4-trifluoromethylphenyl)methanone; 5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone; Valerophenone analog; 5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one; Fluvoxketone

Mots-clés
Metabolites.
Impurities
Fine Chemicals
Pharmaceutical Standards
Intermediates
slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Fluvoxamine EP Impurity D is a structurally related compound that can be present as a process- or degradation-related impurity of fluvoxamine. It is characterized and controlled during pharmaceutical development and quality testing to maintain the required purity of the active pharmaceutical ingredient (API). Monitoring this impurity helps ensure the quality, stability, and compliance of fluvoxamine with pharmacopoeial specifications.